Results 181 to 190 of about 229,255 (286)

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Alteration in epigenetic profile in subclinical atherosclerosis and in high uric acid. [PDF]

Sci Rep
Beik-Khormizi M, Zare-Khormizi MR, Firoozabadi AD, Vakili M, Hekmatimoghaddam S, Pourrajab F.   +5 more
europepmc   +1 more source

Does Uric Acid taken by mouth increase the Excretion of that substance in the Urine?

, 1893
Alexander Haig
openalex   +2 more sources

Prognostic impact of peak oxygen consumption in heart failure: A systematic review and meta‐analysis

ESC Heart Failure, EarlyView.
Based on 64 studies, each 1 mL/kg/min increase in VO2peak significantly reduced all‐cause mortality (HR: 0.86, 95% CI 0.82–0.90) and combined outcomes of ventricular assist device, transplant and all‐cause mortality (HR: 0.84, 95% CI 0.79–0.89) in patients with heart failure, though no significant association was observed with cardiovascular mortality (
Konstantinos Prokopidis, Krzysztof Irlik, Julia Piaśnik, Zuzanna Michalska, Mirela Hendel, Katarzyna Nabrdalik, Gregory Y.H. Lip   +6 more
wiley   +1 more source

Uric Acid, Colchicine and Chronic Inflammatory Diseases: A Cardiovascular Perspective. [PDF]

Metabolites
Alunno A, Carubbi F, Ferri C.
europepmc   +1 more source

Clinical characteristics and outcomes of adults with acute heart failure in a South African teaching hospital

ESC Heart Failure, EarlyView.
In this study of 406 adults admitted with acute heart failure, the overall in‐hospital mortality rate was 3.4%. Independent predictors of in‐hospital mortality included elevated neutrophil‐lymphocyte ratio, C‐reactive protein, and potassium levels, along with moderate or severe aortic regurgitation and lower diastolic blood pressure.
Umar G. Adamu, Muzi Maseko, Nqoba Tsabedze   +2 more
wiley   +1 more source

Hyperuricaemia in type 1 Gaucher disease: is uric acid a biomarker for disease severity? [PDF]

Intern Med J
Hexner-Erlichman Z, Watad S, Szer J, Habashi N, Rosenbaum H.   +4 more
europepmc   +1 more source

A NEW (COLORIMETRIC) METHOD FOR THE DETERMINATION OF URIC ACID IN BLOOD

, 1913
Otto Folin, W. Denis
openalex   +1 more source

THE EFFECT OF PHENYLBUTAZONE ON URIC ACID METABOLISM IN TWO NORMAL SUBJECTS [PDF]

, 1955
James Β. Wyngaarden
openalex   +1 more source

End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)

European Journal of Heart Failure, EarlyView.
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors, Marco Metra, Douwe Postmus, Barry H. Greenberg, Gadi Cotter, Beth A. Davison, Iris E. Beldhuis, G. Michael Felker, Gerasimos Filippatos, Peter S. Pang, Piotr Ponikowski, Claudio Gimpelewicz, John R. Teerlink   +12 more
wiley   +1 more source